A drug-drug interaction study of Lanabecestat (LY3314814) in healthy participants

Trial Identifier:	15997
Sponsor:	AstraZeneca
Collaborator:	Eli Lilly and Company
NCTID::	NCT02568397
Start Date:	October 2015
Primary Completion Date:	January 2016
Study Completion Date:	January 2016
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States, TX	Dallas, TX, United States, 75247

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.